Marwan Saoud1, Musa Saeed2, Sumit Patel2, M Jeffery Mador2. 1. Western New York Veterans Affairs Healthcare System, University at Buffalo, Buffalo, USA. marwan.s.86@gmail.com. 2. Western New York Veterans Affairs Healthcare System, University at Buffalo, Buffalo, USA.
Abstract
INTRODUCTION: To determine the 1-year and 3-year adherence rates with Positive Airway Pressure (PAP) therapy in patients with schizophrenia compared to matched controls. METHODS: A case-control retrospective analysis was performed in a Veterans Affairs hospital. All symptomatic patients with schizophrenia ever started on PAP therapy between 2007 and 2015 were compared with controls matched for severity of sleep apnea based on AHI, BMI, and age at the time of diagnosis. RESULTS: Total number of subjects in both groups was 39. Mean AHI among cases and controls was 27.63 ± 22.16 and 33.59 ± 44.04 (p = 0.32), mean BMI was 34.91 ± 5.87 and 33.92 ± 5.21 (p = 0.43), and mean age at diagnosis was 53.6 ± 11.75 and 55.97 ± 11.92 (p = 0.36), respectively. There was no statistically significant difference in PAP use between patients with schizophrenia and controls at 1-year (percent days device use > 4 h-36.43% ± 31.41 vs. 49.09% ± 38.76; p = 0.17) and 3-year (percent days device use > 4 h-42.43 ± 35.50 vs. 60.53 ± 38.56; p = 0.089) visits CONCLUSIONS: PAP adherence and usage is not significantly different among patients with schizophrenia compared to matched controls. Therefore, schizophrenia does not appear to influence CPAP compliance.
INTRODUCTION: To determine the 1-year and 3-year adherence rates with Positive Airway Pressure (PAP) therapy in patients with schizophrenia compared to matched controls. METHODS: A case-control retrospective analysis was performed in a Veterans Affairs hospital. All symptomatic patients with schizophrenia ever started on PAP therapy between 2007 and 2015 were compared with controls matched for severity of sleep apnea based on AHI, BMI, and age at the time of diagnosis. RESULTS: Total number of subjects in both groups was 39. Mean AHI among cases and controls was 27.63 ± 22.16 and 33.59 ± 44.04 (p = 0.32), mean BMI was 34.91 ± 5.87 and 33.92 ± 5.21 (p = 0.43), and mean age at diagnosis was 53.6 ± 11.75 and 55.97 ± 11.92 (p = 0.36), respectively. There was no statistically significant difference in PAP use between patients with schizophrenia and controls at 1-year (percent days device use > 4 h-36.43% ± 31.41 vs. 49.09% ± 38.76; p = 0.17) and 3-year (percent days device use > 4 h-42.43 ± 35.50 vs. 60.53 ± 38.56; p = 0.089) visits CONCLUSIONS: PAP adherence and usage is not significantly different among patients with schizophrenia compared to matched controls. Therefore, schizophrenia does not appear to influence CPAP compliance.
Authors: Hannah Myles; Nicholas Myles; Nick A Antic; Robert Adams; Madhu Chandratilleke; Dennis Liu; Jeremy Mercer; Andrew Vakulin; Andrew Vincent; Gary Wittert; Cherrie Galletly Journal: Schizophr Res Date: 2015-11-24 Impact factor: 4.939
Authors: Jonathan P Lacro; Laura B Dunn; Christian R Dolder; Susan G Leckband; Dilip V Jeste Journal: J Clin Psychiatry Date: 2002-10 Impact factor: 4.384
Authors: Ashli Owen-Smith; Christine Stewart; Carla Green; Brian K Ahmedani; Beth E Waitzfelder; Rebecca Rossom; Laurel A Copeland; Gregory E Simon Journal: Gen Hosp Psychiatry Date: 2015-07-30 Impact factor: 3.238
Authors: Stavros Boufidis; Mary H Kosmidis; Vasilis P Bozikas; Efi Daskalopoulou-Vlahoyianni; Stergios Pitsavas; Athanasios Karavatos Journal: Int J Psychiatry Med Date: 2003 Impact factor: 1.210
Authors: Chamara V Senaratna; Jennifer L Perret; Caroline J Lodge; Adrian J Lowe; Brittany E Campbell; Melanie C Matheson; Garun S Hamilton; Shyamali C Dharmage Journal: Sleep Med Rev Date: 2016-07-18 Impact factor: 11.609
Authors: Nathaniel S Marshall; Keith K H Wong; Stewart R J Cullen; Matthew W Knuiman; Ronald R Grunstein Journal: J Clin Sleep Med Date: 2014-04-15 Impact factor: 4.062
Authors: Julie Kreyenbuhl; Lisa B Dixon; John F McCarthy; Soheil Soliman; Rosalinda V Ignacio; Marcia Valenstein Journal: Schizophr Bull Date: 2008-08-20 Impact factor: 9.306